{"title":"Specialized Medications","description":"\u003cp\u003eExplore specialized medications, including injectable medicines and infusion vials, at Mai Pharmacy. Contact our pharmacy team for product availability.\u003c\/p\u003e","products":[{"product_id":"aclasta-5mg-100ml-infusion-vial","title":"Aclasta 5mg\/100 ml infusion vial","description":"\u003ch2\u003eAclasta 5mg\/100 ml infusion vial\u003c\/h2\u003e\u003cp\u003eAclasta by Novartis contains 5 mg of zoledronic acid in a 100 ml solution for intravenous infusion. Zoledronic acid belongs to the bisphosphonate group of medicines and reduces bone breakdown.\u003c\/p\u003e\u003ch3\u003eWhat is Aclasta used for?\u003c\/h3\u003e\u003cp\u003eAclasta is a prescription medicine used for osteoporosis and Paget's disease of bone. Treatment suitability depends on the patient's condition and medical assessment.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Aclasta.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Novartis.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: zoledronic acid.\u003c\/li\u003e\n\u003cli\u003eStrength: 5 mg\/100 ml.\u003c\/li\u003e\n\u003cli\u003eDosage form: solution for intravenous infusion.\u003c\/li\u003e\n\u003cli\u003ePack: one 100 ml vial.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePossible side effects and precautions\u003c\/h3\u003e\u003cp\u003eReported side effects can include fever, flu-like symptoms, muscle or joint pain, headache and nausea. Kidney function and calcium levels are important considerations before treatment. This summary does not replace the product leaflet.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWhat is the active ingredient in Aclasta?\u003c\/strong\u003e\u003cbr\u003eAclasta contains zoledronic acid, a bisphosphonate medicine.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eIs Aclasta an injection or an infusion?\u003c\/strong\u003e\u003cbr\u003eThis 5mg\/100 ml presentation is a solution for intravenous infusion.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAre all zoledronic acid products interchangeable?\u003c\/strong\u003e\u003cbr\u003eNo. Products may differ in strength, presentation and approved uses. A different brand or strength should not be treated as a direct substitute without medical confirmation.\u003c\/p\u003e","brand":"Novartis","offers":[{"title":"Default Title","offer_id":50948633231525,"sku":"49717","price":2412.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Aclasta_5mg_100ml.jpg?v=1793120889"},{"product_id":"actemra-200mg-10ml-vial","title":"Actemra 200mg\/10 ml infusion vial","description":"\u003ch2\u003eActemra 200mg\/10 ml concentrate for infusion\u003c\/h2\u003e\u003cp\u003eActemra 200mg\/10 ml by Roche contains tocilizumab, a monoclonal antibody that targets interleukin-6 (IL-6) receptors. It is a biological medicine, not an antibiotic.\u003c\/p\u003e\u003ch3\u003eWhat is Actemra used for?\u003c\/h3\u003e\u003cp\u003eActemra is used for rheumatoid arthritis under specialist supervision. The appropriate treatment depends on the diagnosis, previous treatment and the approved indications for the specific presentation.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Actemra.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Roche.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: tocilizumab.\u003c\/li\u003e\n\u003cli\u003eStrength: 200 mg in 10 ml.\u003c\/li\u003e\n\u003cli\u003eDosage form: concentrate for solution for intravenous infusion.\u003c\/li\u003e\n\u003cli\u003ePresentation: one vial.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow does tocilizumab work?\u003c\/h3\u003e\u003cp\u003eTocilizumab blocks IL-6 receptors, helping reduce inflammatory signalling involved in rheumatoid arthritis.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eIs Actemra an antibiotic?\u003c\/strong\u003e\u003cbr\u003eNo. Tocilizumab is a monoclonal antibody and biological medicine.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eIs this presentation for intravenous infusion?\u003c\/strong\u003e\u003cbr\u003eYes. This listing is for the 200mg\/10 ml concentrate for intravenous infusion, not a pre-filled injection pen.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAre different Actemra strengths interchangeable?\u003c\/strong\u003e\u003cbr\u003eThe vial strength and total prescribed dose must match the specialist's treatment plan. A different strength is not a direct one-for-one replacement.\u003c\/p\u003e","brand":"Roche","offers":[{"title":"Default Title","offer_id":50948646600869,"sku":"101660","price":7569.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Actemra_200mg_10_ml_infusion_vial.jpg?v=1793121068"},{"product_id":"actemra-400mg-20ml-infusion-vial","title":"Actemra 400mg\/20 ml infusion vial","description":"\u003ch2\u003eActemra 400mg\/20 ml concentrate for intravenous infusion\u003c\/h2\u003e\u003cp\u003eActemra by Roche contains tocilizumab, a biological monoclonal antibody that blocks interleukin-6 (IL-6) receptors involved in inflammatory signalling. This listing is for the 400 mg\/20 ml vial.\u003c\/p\u003e\u003ch3\u003eWhat is Actemra used for?\u003c\/h3\u003e\u003cp\u003eActemra is used for rheumatoid arthritis under specialist supervision. Intravenous tocilizumab also has specialist uses in certain forms of juvenile idiopathic arthritis and CAR-T-associated cytokine release syndrome, subject to local approved indications and patient eligibility. It is not a general treatment for every inflammatory condition.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Actemra.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Roche.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: tocilizumab.\u003c\/li\u003e\n\u003cli\u003eStrength: 400 mg in 20 ml.\u003c\/li\u003e\n\u003cli\u003eForm: concentrate for solution for intravenous infusion.\u003c\/li\u003e\n\u003cli\u003ePresentation: one vial.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePreparation and administration\u003c\/h3\u003e\u003cp\u003eThis presentation requires preparation and dilution for intravenous infusion. Preparation, infusion rate and monitoring are determined by the clinical team using the manufacturer's instructions and prescribed treatment plan.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eAssessment of infection risk, tuberculosis history, blood counts and liver function may be needed before and during treatment. A history of diverticulitis or other gastrointestinal problems should be discussed with the treating specialist.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include headache, raised blood pressure, infusion or allergic reactions, infections, and changes in liver enzymes or blood cholesterol. The product leaflet provides the full safety information.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWhat does this vial contain?\u003c\/strong\u003e\u003cbr\u003eEach 20 ml vial contains 400 mg of tocilizumab.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eIs this a pre-filled injection pen?\u003c\/strong\u003e\u003cbr\u003eNo. This product is a concentrate for intravenous infusion.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should Actemra be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the storage instructions on the supplied pack and manufacturer's leaflet. Storage requirements after dilution differ from those for an unopened vial.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCan a diluted infusion be kept for later use?\u003c\/strong\u003e\u003cbr\u003eThe clinical team must follow the manufacturer's validated storage limits and aseptic preparation requirements. Do not assume that a prepared infusion remains suitable for later use.\u003c\/p\u003e","brand":"Roche","offers":[{"title":"Default Title","offer_id":50948666032293,"sku":"101661","price":14160.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Actemra_400mg_20_ml_vial.jpg?v=1793121762"},{"product_id":"actemra-80mg-4ml-infusion-vial","title":"Actemra 80mg\/4 ml infusion vial","description":"\u003ch2\u003eActemra 80mg\/4 ml concentrate for intravenous infusion\u003c\/h2\u003e\u003cp\u003eActemra 80mg\/4 ml by Roche contains tocilizumab, a biological monoclonal antibody that blocks interleukin-6 (IL-6) receptors involved in inflammatory signalling. Each vial contains 80 mg in 4 ml, equivalent to 20 mg\/ml.\u003c\/p\u003e\u003ch3\u003eWhat is Actemra used for?\u003c\/h3\u003e\u003cp\u003eActemra is used for rheumatoid arthritis under specialist supervision. Intravenous tocilizumab also has specialist uses in certain forms of juvenile idiopathic arthritis and CAR-T-associated cytokine release syndrome, subject to local approved indications and patient eligibility. The 80 mg vial strength does not by itself determine a patient's dose or suitability for treatment.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Actemra.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Roche.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: tocilizumab.\u003c\/li\u003e\n\u003cli\u003eStrength: 80 mg\/4 ml (20 mg\/ml).\u003c\/li\u003e\n\u003cli\u003eForm: concentrate for solution for intravenous infusion.\u003c\/li\u003e\n\u003cli\u003ePresentation: one vial.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePreparation and use\u003c\/h3\u003e\u003cp\u003eThis presentation requires preparation and dilution for intravenous infusion. The clinical team determines the required dose, preparation, infusion rate and monitoring using the manufacturer's instructions and prescribed treatment plan.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eAssessment of infection risk, tuberculosis history, blood counts and liver function may be needed before and during treatment. Treatment suitability requires individual medical assessment.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include headache, increased blood pressure, infusion or allergic reactions, infections, and changes in liver enzymes or cholesterol. Refer to the product leaflet for complete safety information.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWhat does the 80 mg vial contain?\u003c\/strong\u003e\u003cbr\u003eEach vial contains 80 mg of tocilizumab in 4 ml.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eIs this a children's dose?\u003c\/strong\u003e\u003cbr\u003eNo. The vial strength is not a patient-specific dose. Treatment and dosing depend on the indication and specialist assessment.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eIs this the same presentation as an injection pen?\u003c\/strong\u003e\u003cbr\u003eNo. This product is a concentrate for intravenous infusion.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should the vial be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the storage instructions on the supplied pack and manufacturer's leaflet. Storage requirements after dilution differ from those for an unopened vial.\u003c\/p\u003e","brand":"Roche","offers":[{"title":"Default Title","offer_id":50948669571237,"sku":"101659","price":2763.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Actemra_80mg_4_ml_infusion_vial.jpg?v=1793122168"},{"product_id":"aimovig-70mg-ml-injection-pen","title":"Aimovig 70mg\/ml injection pen","description":"\u003ch2\u003eAimovig 70mg\/ml pre-filled injection pen\u003c\/h2\u003e\u003cp\u003eAimovig contains erenumab, a biological monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor involved in migraine signalling. This 70mg\/ml pre-filled pen is used for migraine prevention in adults.\u003c\/p\u003e\u003ch3\u003eWhat is Aimovig used for?\u003c\/h3\u003e\u003cp\u003eAimovig is a preventive treatment for episodic and chronic migraine. It is intended to help reduce migraine frequency, not to provide immediate relief during an ongoing attack. Suitability depends on individual medical assessment.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Aimovig.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Amgen.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: erenumab.\u003c\/li\u003e\n\u003cli\u003eStrength: 70 mg\/ml.\u003c\/li\u003e\n\u003cli\u003ePresentation: pre-filled injection pen.\u003c\/li\u003e\n\u003cli\u003eRoute: subcutaneous injection.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow it is used\u003c\/h3\u003e\u003cp\u003eAimovig is administered by subcutaneous injection according to the prescribed treatment plan. The dose, injection schedule and device technique should follow the instructions for the supplied pen.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eDiscuss a history of severe constipation, high blood pressure or allergic reactions with the treating doctor. Pregnancy and breastfeeding require individual medical advice.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include injection-site reactions and constipation. Serious allergic reactions, constipation-related complications and new or worsening high blood pressure can occur. Severe or persistent symptoms require prompt medical attention.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWhat is the active ingredient?\u003c\/strong\u003e\u003cbr\u003eAimovig contains erenumab, a CGRP receptor-targeting monoclonal antibody.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eDoes Aimovig stop an ongoing migraine?\u003c\/strong\u003e\u003cbr\u003eNo. It is a preventive medicine, not an acute migraine rescue treatment.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eIs this the 140 mg pen?\u003c\/strong\u003e\u003cbr\u003eNo. This listing is for the 70mg\/ml presentation.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should the pen be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the temperature limits and handling instructions on the supplied pack and leaflet. Do not assume that storage limits for a different market or presentation apply.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWhat if a dose is missed?\u003c\/strong\u003e\u003cbr\u003eFollow the missed-dose instructions in the supplied leaflet or ask the treating clinician before adjusting the schedule.\u003c\/p\u003e","brand":"Amgen","offers":[{"title":"Default Title","offer_id":50948693950629,"sku":"101662","price":8477.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Aimovig_70mg_ml_injection_pen.jpg?v=1793122647"},{"product_id":"ambisome-50mg-intravenous-vial","title":"Ambisome 50mg intravenous infusion vial","description":"\u003ch2\u003eAmbisome 50mg powder for intravenous infusion\u003c\/h2\u003e\u003cp\u003eAmbisome 50mg by Gilead contains amphotericin B in a liposomal formulation. It is a specialist antifungal medicine used for serious systemic fungal infections. The vial contains powder requiring preparation before intravenous infusion; it is not a ready-to-infuse solution.\u003c\/p\u003e\u003ch3\u003eWhat is Ambisome used for?\u003c\/h3\u003e\u003cp\u003eAmbisome is used for serious fungal infections according to the specialist's diagnosis and the locally approved product information. Specialist uses can include selected systemic fungal infections, empirical treatment in patients with persistent fever and neutropenia, and visceral leishmaniasis. Suitability depends on the infection, patient history and treatment protocol.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Ambisome.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Gilead.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: liposomal amphotericin B.\u003c\/li\u003e\n\u003cli\u003eStrength: 50 mg per vial.\u003c\/li\u003e\n\u003cli\u003eForm: powder for preparation of an intravenous infusion.\u003c\/li\u003e\n\u003cli\u003ePresentation: one vial.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eWhy the formulation matters\u003c\/h3\u003e\u003cp\u003eLiposomal amphotericin B differs from other amphotericin B formulations. These products are not interchangeable on a milligram-for-milligram basis. The formulation does not eliminate the risk of kidney problems or infusion reactions.\u003c\/p\u003e\u003ch3\u003ePreparation and administration\u003c\/h3\u003e\u003cp\u003eReconstitution, dilution, compatible infusion fluids and line handling must follow the manufacturer's instructions for the supplied product. Preparation and infusion are managed by the clinical team.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eKidney function and blood electrolyte levels, including potassium and magnesium, may require monitoring. A history of allergy to amphotericin B or any product ingredient must be considered before treatment.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include fever, chills, infusion reactions, nausea, vomiting, diarrhoea, changes in kidney function, and low potassium or magnesium levels. Serious allergic reactions can occur. Refer to the product leaflet for complete safety information.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eIs Ambisome ready for immediate infusion?\u003c\/strong\u003e\u003cbr\u003eNo. The powder must be prepared and diluted according to the manufacturer's instructions.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCan another amphotericin B product replace it directly?\u003c\/strong\u003e\u003cbr\u003eNo. Different formulations require their own dosing and preparation instructions.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should an unopened vial be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the exact storage conditions on the supplied pack and leaflet. Instructions for prepared solutions differ from those for unopened vials.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCan it be mixed with other medicines?\u003c\/strong\u003e\u003cbr\u003eDo not assume compatibility. The clinical team must check the manufacturer's infusion-fluid and line-compatibility instructions.\u003c\/p\u003e","brand":"Gilead","offers":[{"title":"Default Title","offer_id":50948725571749,"sku":"101676","price":2366.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Ambisome_50mg_intravenous_vial.jpg?v=1793122793"},{"product_id":"arixtra-2-5mg-0-5ml-10-prefilled-syringes","title":"Arixtra 2.5mg\/0.5 ml 10 pre-filled syringes","description":"\u003ch2\u003eArixtra 2.5mg\/0.5 ml pre-filled syringes, pack of 10\u003c\/h2\u003e\u003cp\u003eArixtra by Viatris contains fondaparinux sodium, a synthetic anticoagulant that selectively inhibits activated factor X (factor Xa) through antithrombin. It helps prevent blood clot formation. It is not a biological medicine.\u003c\/p\u003e\u003ch3\u003eWhat is Arixtra 2.5mg used for?\u003c\/h3\u003e\u003cp\u003eThis strength is used for prevention of venous blood clots in selected patients, including after certain major operations, according to the prescribed indication and locally approved product information. Other uses and treatment doses depend on individual medical assessment. The 2.5 mg syringe should not be assumed suitable for treating every acute clot.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Arixtra.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Viatris.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: fondaparinux sodium.\u003c\/li\u003e\n\u003cli\u003eStrength: 2.5 mg in 0.5 ml per syringe.\u003c\/li\u003e\n\u003cli\u003eForm: pre-filled syringe for subcutaneous injection.\u003c\/li\u003e\n\u003cli\u003ePack size: 10 syringes.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow it is used\u003c\/h3\u003e\u003cp\u003eUse the prescribed dose and injection schedule. Injection technique and handling of the pre-filled syringe must follow the instructions supplied with the product.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eBleeding risk, kidney function, platelet disorders, other medicines and a history of bacterial endocarditis require medical assessment. Pregnancy and breastfeeding should be discussed with the treating doctor.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include bleeding, bruising, anaemia, injection-site reactions and changes in liver enzymes. Bleeding can be serious; unusual or persistent bleeding requires prompt medical attention. Refer to the product leaflet for complete safety information.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eHow many syringes are included?\u003c\/strong\u003e\u003cbr\u003eThis pack contains 10 pre-filled syringes, each containing 2.5 mg in 0.5 ml.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCan the 7.5 mg syringe replace this strength?\u003c\/strong\u003e\u003cbr\u003eNo. Different strengths are not direct one-for-one substitutes; the product must match the prescription.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWhat if a dose is missed?\u003c\/strong\u003e\u003cbr\u003eAsk the treating clinician for advice before changing the schedule or taking an extra dose.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should Arixtra be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the exact storage and handling instructions on the supplied pack and leaflet.\u003c\/p\u003e","brand":"Viatris","offers":[{"title":"Default Title","offer_id":50948798840997,"sku":"48116","price":3100.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/images_48.jpg?v=1793122911"},{"product_id":"arixtra-7-5mg-0-6ml-10-prefilled-syringes","title":"Arixtra 7.5mg\/0.6 ml 10 pre-filled syringes","description":"\u003ch2\u003eArixtra 7.5mg\/0.6 ml pre-filled syringes, pack of 10\u003c\/h2\u003e\u003cp\u003eArixtra by Viatris contains fondaparinux sodium, a synthetic anticoagulant that selectively inhibits activated factor X (factor Xa) through antithrombin. It helps prevent clot growth and new clot formation. It is not a clot-dissolving medicine.\u003c\/p\u003e\u003ch3\u003eWhat is Arixtra 7.5mg used for?\u003c\/h3\u003e\u003cp\u003eFondaparinux is used in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in suitable patients according to the prescribed treatment plan. The appropriate strength depends on factors including body weight, kidney function and bleeding risk. The 7.5 mg syringe is not suitable for every patient or treatment indication.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Arixtra.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Viatris.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: fondaparinux sodium.\u003c\/li\u003e\n\u003cli\u003eStrength: 7.5 mg in 0.6 ml per syringe.\u003c\/li\u003e\n\u003cli\u003eForm: pre-filled syringe for subcutaneous injection.\u003c\/li\u003e\n\u003cli\u003ePack size: 10 syringes.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow it is used\u003c\/h3\u003e\u003cp\u003eThe dose and treatment schedule must match the prescription. Follow the device instructions supplied with the pre-filled syringes for injection technique and handling.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eActive bleeding, severe kidney impairment, platelet disorders, bacterial endocarditis and other medicines affecting bleeding require medical assessment. Do not choose a strength based on pack size or price.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include bleeding, bruising, anaemia and injection-site reactions, including haematoma. Bleeding can be serious. Unusual or persistent bleeding requires prompt medical attention. Refer to the product leaflet for complete safety information.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eDoes Arixtra dissolve a clot?\u003c\/strong\u003e\u003cbr\u003eNo. It is an anticoagulant, not a thrombolytic medicine. It helps prevent clot growth and new clots while the body processes the existing clot.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWhat is the difference between 2.5 mg and 7.5 mg?\u003c\/strong\u003e\u003cbr\u003eThey contain different amounts of fondaparinux and are used in different prescribed regimens. They are not direct one-for-one substitutes.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow many syringes are included?\u003c\/strong\u003e\u003cbr\u003eThis pack contains 10 syringes, each containing 7.5 mg in 0.6 ml.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should the pack be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the exact storage instructions on the supplied pack and leaflet.\u003c\/p\u003e","brand":"Viatris","offers":[{"title":"Default Title","offer_id":50948824891557,"sku":"61902","price":2559.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Arixtra_7.5mg_0.6_ml_10_pre-filled_syringes.jpg?v=1793123081"},{"product_id":"actilyse-50mg-intravenous-vial","title":"Actilyse 50mg intravenous infusion vial","description":"\u003ch2\u003eActilyse 50mg powder for intravenous infusion\u003c\/h2\u003e\u003cp\u003eActilyse 50mg by Boehringer Ingelheim contains alteplase, a recombinant tissue plasminogen activator (rt-PA). Alteplase promotes the conversion of plasminogen to plasmin, which breaks down fibrin within blood clots. Treatment does not guarantee immediate restoration of blood flow.\u003c\/p\u003e\u003ch3\u003eWhat is Actilyse used for?\u003c\/h3\u003e\u003cp\u003eActilyse is used in selected cases of acute ischaemic stroke, acute myocardial infarction and acute pulmonary embolism under specialist hospital protocols. Eligibility, timing and treatment regimens differ by indication. It is not appropriate for every stroke, heart attack or blood clot.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Actilyse.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Boehringer Ingelheim.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: alteplase.\u003c\/li\u003e\n\u003cli\u003eStrength: 50 mg per vial.\u003c\/li\u003e\n\u003cli\u003eForm: powder for preparation of an intravenous solution.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePreparation and administration\u003c\/h3\u003e\u003cp\u003eReconstitution, dosing, infusion rate and monitoring must follow the manufacturer's instructions and the indication-specific hospital protocol. A single preparation or infusion regimen must not be assumed to apply to every emergency.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eAlteplase can cause severe or fatal bleeding, including bleeding inside the brain. Active bleeding, suspected intracranial haemorrhage, recent surgery or trauma, uncontrolled blood pressure and clotting disorders require specialist assessment. The full contraindications depend on the treatment indication.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible adverse effects include bleeding at injection sites, internal bleeding and allergic reactions. Treatment requires close clinical monitoring. Refer to the product information for complete safety details.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eIs Actilyse the same as Actemra?\u003c\/strong\u003e\u003cbr\u003eNo. Actilyse contains alteplase. Actemra contains tocilizumab and is a different medicine.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCan it be combined with other blood-thinning medicines?\u003c\/strong\u003e\u003cbr\u003eAnticoagulants and antiplatelet medicines can increase bleeding risk. Any combination and its timing must be managed by the specialist clinical team.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow long can the prepared solution be kept?\u003c\/strong\u003e\u003cbr\u003eThe clinical team must follow the manufacturer's validated storage and aseptic preparation instructions for the supplied product.\u003c\/p\u003e\u003cp\u003eThis product page is not an emergency treatment service. Suspected stroke, heart attack or pulmonary embolism requires immediate emergency care.\u003c\/p\u003e","brand":"Boehringer Ingelheim","offers":[{"title":"Default Title","offer_id":50948847173797,"sku":"27849","price":21997.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/images_50.jpg?v=1793123139"},{"product_id":"adcetris-50mg-infusion-vial","title":"Adcetris 50mg infusion vial","description":"\u003ch2\u003eAdcetris 50mg powder for intravenous infusion\u003c\/h2\u003e\u003cp\u003eAdcetris by Takeda contains brentuximab vedotin, an antibody-drug conjugate that combines a CD30-targeting monoclonal antibody with a cell-killing medicine. Targeted treatment can still affect healthy tissues and cause serious side effects.\u003c\/p\u003e\u003ch3\u003eWhat is Adcetris used for?\u003c\/h3\u003e\u003cp\u003eAdcetris is used in selected lymphoma treatment regimens, including certain cases of Hodgkin lymphoma, systemic anaplastic large cell lymphoma and CD30-positive cutaneous T-cell lymphoma. Eligibility depends on the specific diagnosis, disease markers, prior treatment and locally approved product information.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Adcetris.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Takeda.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: brentuximab vedotin.\u003c\/li\u003e\n\u003cli\u003eStrength: 50 mg per vial.\u003c\/li\u003e\n\u003cli\u003eForm: powder for preparation of an intravenous infusion.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePreparation and treatment schedule\u003c\/h3\u003e\u003cp\u003eReconstitution, dilution, dose selection, infusion timing and treatment cycles are managed by the oncology team using the manufacturer's instructions and the prescribed regimen. Treatment schedules vary; there is no single schedule or cycle count suitable for every patient.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eImportant risks include peripheral neuropathy, low blood cell counts, serious infections and rare serious neurological complications such as progressive multifocal leukoencephalopathy (PML). Combination with bleomycin presents a serious lung-toxicity risk and must be checked against the approved product information. Pregnancy, breastfeeding and contraception require specialist advice.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include tingling or numbness in the hands or feet, fatigue, nausea, diarrhoea, constipation and reduced white blood cell counts. New neurological symptoms or signs of infection require prompt medical attention. Refer to the product leaflet for full safety information.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWhat does Adcetris target?\u003c\/strong\u003e\u003cbr\u003eBrentuximab vedotin targets CD30, a protein found on certain lymphoma cells.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow many treatment cycles are needed?\u003c\/strong\u003e\u003cbr\u003eThe oncology team determines the number of cycles according to the treatment regimen, response and side effects. A product listing cannot predict cure or treatment duration.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should the vial be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the exact storage instructions on the supplied pack and manufacturer's leaflet. Prepared infusions have separate handling and storage requirements.\u003c\/p\u003e","brand":"Takeda","offers":[{"title":"Default Title","offer_id":50948865458341,"sku":"101677","price":69296.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Adcetris_50mg_infusion_vial.jpg?v=1793123320"},{"product_id":"avastin-100mg-4ml-infusion-vial","title":"Avastin 100mg\/4 ml infusion vial","description":"\u003ch2\u003eAvastin 100mg\/4 ml concentrate for intravenous infusion\u003c\/h2\u003e\u003cp\u003eAvastin by Roche contains bevacizumab, a biological monoclonal antibody that targets vascular endothelial growth factor (VEGF). It helps inhibit the formation of new blood vessels that support tumour growth. Treatment response varies.\u003c\/p\u003e\u003ch3\u003eWhat is Avastin used for?\u003c\/h3\u003e\u003cp\u003eBevacizumab is used in selected treatment regimens for cancers such as colorectal, certain non-small cell lung, kidney, ovarian, cervical and liver cancers. Eligibility and treatment combinations depend on the specific diagnosis, prior therapy and locally approved product information. It is not suitable for every cancer or every patient.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Avastin.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Roche.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: bevacizumab.\u003c\/li\u003e\n\u003cli\u003eStrength: 100 mg in 4 ml.\u003c\/li\u003e\n\u003cli\u003eForm: concentrate for solution for intravenous infusion.\u003c\/li\u003e\n\u003cli\u003ePresentation: one vial.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePreparation and administration\u003c\/h3\u003e\u003cp\u003eThe oncology team determines the dose, treatment interval, dilution and infusion rate using the prescribed regimen and manufacturer's instructions. This listing describes the intravenous oncology presentation.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eImportant risks include bleeding, impaired wound healing, high blood pressure, blood clots, gastrointestinal perforation and protein in the urine. Recent or planned surgery, pregnancy, breastfeeding and other treatments require specialist assessment.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include raised blood pressure, headache, nosebleeds, changes in taste and skin symptoms. Serious complications can occur. Refer to the product leaflet for complete safety information.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWhat does this vial contain?\u003c\/strong\u003e\u003cbr\u003eEach 4 ml vial contains 100 mg of bevacizumab.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCan a bevacizumab biosimilar be substituted directly?\u003c\/strong\u003e\u003cbr\u003eProduct choice and switching require confirmation by the treating oncology team. This page does not establish local approval, availability or interchangeability of another brand.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCan hair loss occur during treatment?\u003c\/strong\u003e\u003cbr\u003eSide effects depend on the full treatment regimen, including accompanying chemotherapy. Hair changes should be discussed with the oncology team.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should the vial be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the exact storage and handling instructions on the supplied pack and manufacturer's leaflet.\u003c\/p\u003e","brand":"Roche","offers":[{"title":"Default Title","offer_id":50948894949541,"sku":"101681","price":7056.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Avastin_100mg_4_ml_infusion_vial.jpg?v=1793123538"},{"product_id":"avastin-400mg-16ml-infusion-vial","title":"Avastin 400mg\/16 ml infusion vial","description":"\u003ch2\u003eAvastin 400mg\/16 ml concentrate for intravenous infusion\u003c\/h2\u003e\u003cp\u003eAvastin by Roche contains bevacizumab, a biological monoclonal antibody that targets vascular endothelial growth factor (VEGF). It helps inhibit the formation of new blood vessels that support tumour growth. Treatment response varies.\u003c\/p\u003e\u003ch3\u003eWhat is Avastin used for?\u003c\/h3\u003e\u003cp\u003eBevacizumab is used in selected treatment regimens for cancers such as colorectal, certain non-small cell lung, kidney, ovarian, cervical and liver cancers. Eligibility and treatment combinations depend on the specific diagnosis, prior therapy and locally approved product information. It is not suitable for every cancer or every patient.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Avastin.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Roche.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: bevacizumab.\u003c\/li\u003e\n\u003cli\u003eTotal content: 400 mg in 16 ml.\u003c\/li\u003e\n\u003cli\u003eConcentration: 25 mg\/ml.\u003c\/li\u003e\n\u003cli\u003eForm: concentrate for solution for intravenous infusion.\u003c\/li\u003e\n\u003cli\u003ePresentation: one vial.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003e400 mg and 100 mg vial comparison\u003c\/h3\u003e\u003cp\u003eThe 400mg\/16 ml vial contains more total medicine than the 100mg\/4 ml vial. Both presentations have the same concentration of 25 mg\/ml. Vial size does not determine the patient's prescribed dose.\u003c\/p\u003e\u003ch3\u003ePreparation and administration\u003c\/h3\u003e\u003cp\u003eThe oncology team determines the dose, dilution, treatment interval and infusion rate using the prescribed regimen and manufacturer's instructions. This page describes the intravenous oncology presentation.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eImportant risks include bleeding, impaired wound healing, high blood pressure, blood clots, gastrointestinal perforation and protein in the urine. Recent or planned surgery, pregnancy, breastfeeding and other treatments require specialist assessment.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include raised blood pressure, headache, nosebleeds, changes in taste and skin symptoms. Serious complications can occur. Refer to the product leaflet for complete safety information.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eIs the 400 mg vial more concentrated than the 100 mg vial?\u003c\/strong\u003e\u003cbr\u003eNo. Both contain 25 mg\/ml. The 400 mg vial has a larger volume and more total medicine.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCan a bevacizumab biosimilar be substituted directly?\u003c\/strong\u003e\u003cbr\u003eProduct choice and switching require confirmation by the treating oncology team. This page does not establish local approval, availability or interchangeability of another brand.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCan hair loss occur during treatment?\u003c\/strong\u003e\u003cbr\u003eSide effects depend on the full treatment regimen, including accompanying chemotherapy. Discuss hair changes with the oncology team.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should the vial be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the exact storage and handling instructions on the supplied pack and manufacturer's leaflet.\u003c\/p\u003e","brand":"Roche","offers":[{"title":"Default Title","offer_id":50948907532453,"sku":"101682","price":23529.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/images_53.jpg?v=1793123626"}],"url":"https:\/\/maipharmacy.co\/ar\/collections\/specialized-medications.oembed","provider":"Mai Pharmacy","version":"1.0","type":"link"}